Skip to content

To evaluate the efficacy of kakodumbar phalarasa in the management of asrigdara with special reference to menorrhagia.

Randmised controlled clinical trial to evaluate the efficacy of kakodumbar phalarasa in the management of Asrigdara with special reference to menorrhagia - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091706
Enrollment
60
Registered
2025-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Sponsors

LKR Ayurvedic Mahavidyala Pg training and Research centreGadhinglaj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between the age group 18-45 years. 2.Patients with Pratyatma Lakshanas of Asrigdara like atyadhik raktstrav,angmard,adhoudharshool. 3.Patient having no any systemic disease

Exclusion criteria

Exclusion criteria: 1.Diagnosed patients with uterine & pelvic pathology. 2.Diagnosed patient with any serious systemic disorder. 3.K/C/O Abortion/ ectopic pregnancy. 4.Patient taking Anti-coagulation therapy and having any coagulant defects like Thrombocytopenic Purpura

Design outcomes

Primary

MeasureTime frame
the parameters will be noted down before and after treatment.patient will be diagnosed based on symptoms of asrugdara.Explained in Ayurvedic and modern texts. 1.rajastrav avadhi 2.angamard 3.adhoudharshool 4.katishoola 3.rajapramanTimepoint: 3rd,5th,7th day of 3 consecutive cycles

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public Contactvd Samruddhi Shivajirao Thombre

L.K.R. Ayurvedic Mahavidyala Pg training and Research centre,Gadhinglaj

drsuhasthorat26@gmail.com9850366952

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026